Professor Ian Peake

School of Medicine and Population Health

Emeritus Professor of Molecular Medicine

i.r.peake@sheffield.ac.uk
+44 7785 247 928
The Medical School

Full contact details

Professor Ian Peake
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk

I joined the University in 1990 as the Sir Edward Mellanby Professor of Molecular Medicine and also hold an Honorary Consultant position with the Sheffield Teaching Hospitals NHS Foundation Trust. I have been Deputy Director of the Division of Genomic Medicine and Director of Research for Medicine.

I am currently focused on my research into inherited bleeding disorders in particular von Willebrands disease.

Research interests

My research interests are inherited disorders of Haemostasis and Thrombosis.

My current research interests focus on von Willebrands Disease. I was a co-applicant on an NIH funded PPG (the Zimmerman Project) with collaborators in Canada and USA. I also co-chaired the EU von Willebrands disease collaborative group which has projects continuing from the EU funded MCMDM-1VWD project which I directed.

Since 2011 I have been a coordinator of an International EU/Iran study of severe Von Willebrands Disease (3WINTERS IPS) sponsored by the a Medical research Charity in Milan Italy.

Publications

Show: Featured publications All publications

Journal articles

  • Tosetto A, Badiee Z, Baghaipour M, Baronciani L, Battle J, Berntorp E, Bodó I, Budde U, Castaman G, Eikenboom JCJ , Eshghi P et al (2020) . Journal of Thrombosis and Haemostasis, 18(9), 2145-2154.
  • Mufti AH, Ogiwara K, Swystun LL, Eikenboom JCJ, Budde U, Hopman WM, Halldén C, Goudemand J, Peake IR, Goodeve AC , Lillicrap D et al (2018) . Blood Advances, 2(13), 1585-1594.
  • Cartwright A, Peake IR, Goodeve AC & Hampshire DJ (2016) . Haemophilia.
  • Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, Udani RA, Dasgupta M, Hoffmann RG, Ragni MV , Shapiro AD et al (2016) . Blood, 127(20), 2481-2488.
  • Hampshire DJ, Abuzenadah AM, Cartwright A, Al-Shammari NS, Coyle RE, Eckert M, Al-Buhairan AM, Messenger SL, Budde U, Gürsel T , Ingerslev J et al (2013) . Thrombosis and Haemostasis, 110(2), 264-274.
  • Eikenboom J, Federici AB, Dirven RJ, Castaman G, Rodeghiero F, Budde U, Schneppenheim R, Batlle J, Canciani MT, Goudemand J , Peake I et al (2013) . Blood, 121(12), 2336-2339.
  • Hickson N, Hampshire D, Winship P, Goudemand J, Schneppenheim R, Budde U, Castaman G, Rodeghiero F, Federici AB, James P , Peake I et al (2010) . Journal Of Thrombosis And Haemostasis, 8(9), 1986-1993.
  • PEAKE IR & GOODEVE AC (2010) . Journal of Thrombosis and Haemostasis, 8(1), 13-16.
  • BUDDE U, SCHNEPPENHEIM R, EIKENBOOM J, GOODEVE A, WILL K, DREWKE E, CASTAMAN G, RODEGHIERO F, FEDERICI AB, BATLLE J , PÉREZ A et al (2008) . Journal of Thrombosis and Haemostasis, 6(5), 762-771.
  • Castaman G, Lethagen S, Federici AB, Tosetto A, Goodeve A, Budde U, Batlle J, Meyer D, Mazurier C, Fressinaud E , Goudemand J et al (2008) . Blood, 111(7), 3531-3539.
  • PEAKE I & GOODEVE A (2007) . Journal of Thrombosis and Haemostasis, 5, 7-11.
  • Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R , Budde U et al (2007) . Blood, 109(1), 112-121.
  • EIKENBOOM J, VAN MARION V, PUTTER H, GOODEVE A, RODEGHIERO F, CASTAMAN G, FEDERICI AB, BATLLE J, MEYER D, MAZURIER C , GOUDEMAND J et al (2006) . Journal of Thrombosis and Haemostasis, 4(4), 774-782.
  • TOSETTO A, RODEGHIERO F, CASTAMAN G, GOODEVE A, FEDERICI AB, BATLLE J, MEYER D, FRESSINAUD E, MAZURIER C, GOUDEMAND J , EIKENBOOM J et al (2006) . Journal of Thrombosis and Haemostasis, 4(4), 766-773.

Conference proceedings

  • Federici AB, Badiee Z, Baghaipour M-R, Castaman G, Eshghi P, Goudemand J, Hay CRM, Hoorfar H, Karimi M, Keikhaei B , Lassila R et al (2018) . Blood, Vol. 132(Supplement 1) (pp 2464-2464)

All publications

Journal articles

  • Baronciani L, Peake I, Schneppenheim R, Goodeve A, Ahmadinejad M, Badiee Z, Baghaipour M-R, Benitez O, Bodó I, Budde U , Cairo A et al (2021) . Blood Advances, 5(15), 2987-3001.
  • Tosetto A, Badiee Z, Baghaipour M, Baronciani L, Battle J, Berntorp E, Bodó I, Budde U, Castaman G, Eikenboom JCJ , Eshghi P et al (2020) . Journal of Thrombosis and Haemostasis, 18(9), 2145-2154.
  • Cartwright A, Webster SJ, de Jong A, Dirven RJ, Bloomer LDS, AL-Buhairan AM, Budde U, Halldén C, Habart D, Goudemand J , Peake IR et al (2020) . Blood Advances, 4(13), 2979-2990.
  • Mufti AH, Ogiwara K, Swystun LL, Eikenboom JCJ, Budde U, Hopman WM, Halldén C, Goudemand J, Peake IR, Goodeve AC , Lillicrap D et al (2018) . Blood Advances, 2(13), 1585-1594.
  • Cartwright A, Peake IR, Goodeve AC & Hampshire DJ (2016) . Haemophilia.
  • Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, Udani RA, Dasgupta M, Hoffmann RG, Ragni MV , Shapiro AD et al (2016) . Blood, 127(20), 2481-2488.
  • Stockley J, Nisar SP, Leo VC, Sabi E, Cunningham MR, Eikenboom JC, Lethagen S, Schneppenheim R, Goodeve AC, Watson SP , Mundell SJ et al (2015) . PLoS ONE, 10(12).
  • Hampshire DJ, Abuzenadah AM, Cartwright A, Al-Shammari NS, Coyle RE, Eckert M, Al-Buhairan AM, Messenger SL, Budde U, Gürsel T , Ingerslev J et al (2013) . Thrombosis and Haemostasis, 110(2), 264-274.
  • Eikenboom J, Federici AB, Dirven RJ, Castaman G, Rodeghiero F, Budde U, Schneppenheim R, Batlle J, Canciani MT, Goudemand J , Peake I et al (2013) . Blood, 121(12), 2336-2339.
  • Cartwright A, Peake IR & Goodeve AC (2013) Applying in silico analysis to the historically reported VWF exon 42 deletion reveals a probable L1 non-autonomous retrotransposition mediated deletion pathomechanism. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 11, 175-175.
  • Schneppenheim R, Budde U, Batlle J, Castaman G, Eikenboom JCJ, Federici AB, Goudemand J, Obser T, Oyen F, Rodeghiero F , Schneppenheim S et al (2012) . Blood, 120(21), 99-99.
  • Berntorp E, Peake I, Budde U, Laffan M, Montgomery R, Windyga J, Goodeve A, Petrini P, von Depka M, Miesbach W , Lillicrap D et al (2012) . Haemophilia, 18(s6), 1-13.
  • Hickson N, Hampshire D, Castaman G, Eikenboom J, Rodeghiero F, Peake I, Goodeve A & Study Groups ZPMCB-VWDA-V (2011) . Journal of Thrombosis and Haemostasis, 9(3), 603-605.
  • TOSETTO A, RODEGHIERO F, CASTAMAN G, GOODEVE A, FEDERICI AB, BATLLE J, MEYER D, GOUDEMAND J, EIKENBOOM J, SCHNEPPENHEIM R , BUDDE U et al (2011) . Haemophilia, 17(1), 165-166.
  • Hampshire DJ, Burghel GJ, Goudemand J, Bouvet LCS, Eikenboom JCJ, Schneppenheim R, Budde U, Peake IR & Goodeve AC (2010) . Haematologica, 95(12), 2163-2165.
  • Hampshire DJ, Bloomer LD, Al-Buhairan AM, Coyle RE, Vijzelaar RNCP, Lillicrap D, James PD, Eikenboom JCJ, Schneppenheim R, Rodeghiero F , Montgomery RR et al (2010) . Blood, 116(21), 2218-2218.
  • Hickson N, Hampshire D, Winship P, Goudemand J, Schneppenheim R, Budde U, Castaman G, Rodeghiero F, Federici AB, James P , Peake I et al (2010) . Journal Of Thrombosis And Haemostasis, 8(9), 1986-1993.
  • Castaman G, Tosetto A, Goodeve A, Federici AB, Lethagen S, Budde U, Batlle J, Meyer D, Mazurier C, Goudemand J , Eikenboom J et al (2010) . British Journal of Haematology, 151(3), 245-251.
  • Castaman G, Tosetto A, Cappelletti A, Goodeve A, Federici AB, Batlle J, Meyer D, Goudemand J, Eikenboom JCJ, Schneppenheim R , Budde U et al (2010) . Thrombosis Research, 126(3), 227-231.
  • PEAKE IR & GOODEVE AC (2010) . Journal of Thrombosis and Haemostasis, 8(1), 13-16.
  • Daly ME, Dawood BB, Lester WA, Peake IR, Rodeghiero F, Goodeve AC, Makris M, Wilde JT, Mumford AD, Watson SP & Mundell SJ (2009) . Blood, 113(17), 4110-4113.
  • Eikenboom JCJ, Hilbert L, Ribba AS, Hommais A, Habart D, Messenger S, Al-Buhairan A, Guilliatt A, Lester W & Mazurier C (2009) . Journal of Thrombosis and Haemostasis, 7(8), 1304-1312.
  • HASHEMI SOTEH SMB, ANSON J, INBAL A, PEAKE IR & GOODEVE AC (2008) . Haemophilia, 14(3), 621-624.
  • Haberichter SL, Castaman G, Budde U, Peake I, Goodeve A, Rodeghiero F, Federici AB, Batlle J, Meyer D, Mazurier C , Goudemand J et al (2008) . Blood, 111(10), 4979-4985.
  • BUDDE U, SCHNEPPENHEIM R, EIKENBOOM J, GOODEVE A, WILL K, DREWKE E, CASTAMAN G, RODEGHIERO F, FEDERICI AB, BATLLE J , PÉREZ A et al (2008) . Journal of Thrombosis and Haemostasis, 6(5), 762-771.
  • Castaman G, Lethagen S, Federici AB, Tosetto A, Goodeve A, Budde U, Batlle J, Meyer D, Mazurier C, Fressinaud E , Goudemand J et al (2008) . Blood, 111(7), 3531-3539.
  • PEAKE I & GOODEVE A (2007) . Journal of Thrombosis and Haemostasis, 5, 7-11.
  • TOSETTO A, RODEGHIERO F, CASTAMAN G, BERNARDI M, BERTONCELLO K, GOODEVE A, FEDERICI AB, BATLLE J, MEYER D, MAZURIER C , GOUDEMAND J et al (2007) . Journal of Thrombosis and Haemostasis, 5(4), 715-721.
  • Soteh MH, Peake IR, Marsden L, Anson J, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J & Goodeve A (2007) . Haematologica, 92(4), 550-553.
  • Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R , Budde U et al (2007) . Blood, 109(1), 112-121.
  • Hall AJ, Peake IR & Winship PR (2006) . British Journal of Haematology, 135(4), 538-546.
  • SADLER JE, BUDDE U, EIKENBOOM JCJ, FAVALORO EJ, HILL FGH, HOLMBERG L, INGERSLEV J, LEE CA, LILLICRAP D, MANNUCCI PM , MAZURIER C et al (2006) . Journal of Thrombosis and Haemostasis, 4(10), 2103-2114.
  • EIKENBOOM J, VAN MARION V, PUTTER H, GOODEVE A, RODEGHIERO F, CASTAMAN G, FEDERICI AB, BATLLE J, MEYER D, MAZURIER C , GOUDEMAND J et al (2006) . Journal of Thrombosis and Haemostasis, 4(4), 774-782.
  • TOSETTO A, RODEGHIERO F, CASTAMAN G, GOODEVE A, FEDERICI AB, BATLLE J, MEYER D, FRESSINAUD E, MAZURIER C, GOUDEMAND J , EIKENBOOM J et al (2006) . Journal of Thrombosis and Haemostasis, 4(4), 766-773.
  • Ludlam CA, Pasi KJ, Bolton‐Maggs P, Collins PW, Cumming AM, Dolan G, Fryer A, Harrington C, Hill FGH, Peake IR , Perry DJ et al (2005) . Haemophilia, 11(2), 145-163.
  • Kunicki TJ, Federici AB, Salomon DR, Koziol JA, Head SR, Mondala TS, Chismar JD, Baronciani L, Canciani MT & Peake IR (2004) . Blood, 104(8), 2359-2367.
  • Laffan M, Brown SA, Collins PW, Cumming AM, Hill FGH, Keeling D, Peake IR & Pasi KJ (2004) . Haemophilia, 10(3), 199-217.
  • Pasi KJ, Collins PW, Keeling DM, Brown SA, Cumming AM, Dolan GC, Hay CRM, Hill FGH, Laffan M & Peake IR (2004) . Haemophilia, 10(3), 218-231.
  • Johan MF, Bowen DT, Frew ME, Goodeve AC, Wilson GA, Peake IR & Reilly JT (2004) . British Journal of Haematology, 124(6), 843-844.
  • Marsden L, Peake IR, Daly ME & Croft SA (2003) . Journal of Thrombosis and Haemostasis, 1, P1662-P1662.
  • Abu‐Duhier FM, Goodeve AC, Wilson GA, Peake IR & Reilly JT (2003) . British Journal of Haematology, 123(4), 749-750.
  • Care RS, Valk PJM, Goodeve AC, Abu‐Duhier FM, Geertsma‐Kleinekoort WMC, Wilson GA, Gari MA, Peake IR, Löwenberg B & Reilly JT (2003) . British Journal of Haematology, 121(5), 775-777.
  • Abu‐Duhier FM, Goodeve AC, Care RS, Gari M, Wilson GA, Peake IR & Reilly JT (2003) . British Journal of Haematology, 120(3), 464-470.
  • Goodeve AC & Peake IR (2003) . Seminars in Thrombosis and Hemostasis, 29(1), 023-030.
  • Hallworth M, Hyde K, Cumming A & Peake I (2002) . Clinical & Laboratory Haematology, 24(4), 197-204.
  • Abu-Duhier FM, Goodeve AC, Wilson GA, Carr RS, Peake IR & Reilly JT (2002) . Blood, 100(1), 364-364.
  • Di Bitondo R (2002) . Human Molecular Genetics, 11(7), 723-731.
  • Eikenboom JCJ, Ginsburg D, Hilbert L, Mazurier C, Peake IR, Sadler JE, Rodeghiero F & Goodeve AC (2001) . Thrombosis and Haemostasis, 85(05), 929-931.
  • Wilson G, Forrest P, Heppinstall S, Green BN, Goodeve AC, Peake IR, Reilly JT, Porter N & Rees DC (2001) . Hemoglobin, 25(3), 337-340.
  • Abu‐Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR & Reilly JT (2001) . British Journal of Haematology, 113(4), 1076-1077.
  • Abu‐Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR & Reilly JT (2001) . British Journal of Haematology, 113(4), 983-988.
  • Wilson GA, Pollitt RC, Coelho D, Goodeve AC, Peake IR, Reilly JT & Vandenberghe EA (2001) Routine use of RT-PCR for the detection of TCR gene rearrangement. LEUKEMIA, 15(12), 2010-2010.
  • Abu-Duhier FM, Goodeve AC, Wilson GA, Care RS, Peake IR & Reilly JT (2001) Novel c-fms mutations in acute and chronic myeloproliferative disorders. Blood, 98(11 PART I).
  • Leuer M, Oldenburg J, Lavergne J-M, Ludwig M, Fregin A, Eigel A, Ljung R, Goodeve A, Peake I & Olek K (2001) . The American Journal of Human Genetics, 69(1), 75-87.
  • Goodeve A & Peake I (2001) . Best Practice & Research Clinical Haematology, 14(2), 235-240.
  • Allen S, Goodeve AC, Peake IR & Daly ME (2001) . Biochemical and Biophysical Research Communications, 280(2), 448-453.
  • Williams I, Bray G, Peake I & Goodeve A (2000) . Thrombosis and Haemostasis, 83(06), 844-848.
  • Goodeve AC, Williams I, Bray GL & Peake IR (2000) Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.. Thromb Haemost, 83(6), 844-848.
  • Beauchamp NJ, Makris M, Preston FE, Peake IR & Daly ME (2000) . Thrombosis and Haemostasis, 83(05), 715-721.
  • Abu‐Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, Vandenberghe EA, Winship PR & Reilly JT (2000) . British Journal of Haematology, 111(1), 190-195.
  • Wilson GA, Vandenberghe EA, Pollitt RC, Rees DC, Goodeve AC, Peake IR & Reilly JT (2000) . British Journal of Haematology, 111(4), 1109-1111.
  • Visanji JM, Seargent J, Tahri D, Croft SA, Makris M, Preston FE, Peake IR & Daly ME (2000) . British Journal of Haematology, 110(1), 135-138.
  • Wilson GA, Vandenberghe EA, Pollitt RC, Rees DC, Goodeve AC, Peake IR & Reilly JT (2000) . British Journal of Haematology, 111(4), 1109-1111.
  • Abu-Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, Vandenberghe EA, Winship PR & Reilly JT (2000) . British Journal of Haematology, 111(1), 190-195.
  • Allen S, Abuzenadah AM, Hinks J, Blagg JL, Gursel T, Ingerslev J, Goodeve AC, Peake IR & Daly ME (2000) . Blood, 96(2), 560-568.
  • Allen S, Abuzenadah AM, Hinks J, Blagg JL, Gursel T, Ingerslev J, Goodeve AC, Peake IR & Daly ME (2000) . Blood, 96(2), 560-568.
  • Allen S, Abuzenadah AM, Blagg JL, Hinks J, Nesbitt IM, Goodeve AC, Gursel T, Ingerslev J, Peake IR & Daly ME (2000) . Blood, 95(6), 2000-2007.
  • Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, Bayliss P, Peake IR, Miller GJ & Preston FE (2000) . Blood, 95(6), 1935-1941.
  • Hampton K, Preston FE, Peake I, Goodeve A & Nesbitt IM (1999) . Thrombosis and Haemostasis, 82(09), 1061-1064.
  • DiMichele D, Mertens K, Negrier C, Peake I, Prowse C, Schwaab R, Yoshioka A, Ingerslev J & White G (1999) . Thrombosis and Haemostasis, 81(03), 462-462.
  • Coughlan TC, Blagg JL, Abulola M, Daly ME, Hampton KK, Makris M, Peake IR & Goodeve AC (1999) . Thrombosis and Haemostasis, 82(10), 1373-1375.
  • Gari M, Goodeve A, Wilson G, Winship P, Langabeer S, Linch D, Vandenberghe E, Peake I & Reilly J (1999) . British Journal of Haematology, 105(4), 894-900.
  • Hinks JL, Winship PR, Makris M, Preston FE, Peake IR & Goodeve AC (1999) . British Journal of Haematology, 104(4), 915-918.
  • Frost L, Wilson G, Goodeve A, Peake I & Vora A (1999) Intensity of prior therapy influences minimal residual disease (MRD) detection and its clinical significance in childhood lymphoblastic leukaemia (ALL).. BLOOD, 94(10), 203B-203B.
  • Curtis D, Durkie M, Balac (Morris) P, Sheard D, Goodeve A, Peake I, Quarrell O & Tanner S (1999) . Human Mutation, 14(4), 304-311.
  • Beauchamp NJ, Makris M, Preston FE, Peake IR & Daly ME (1999) Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency. THROMBOSIS AND HAEMOSTASIS, 517-518.
  • Daly ME, Seargent J, Tahri D, Croft SA, Makris M, Preston FE & Peake IR (1999) The 46 allele of the-675 4G/5G dimorphism in the PAI-1 promoter increases thrombotic risk in patients with factor V Leiden. THROMBOSIS AND HAEMOSTASIS, 668-668.
  • Abuzenadah AM, Gursel T, Ingerslev J, Nesbitt IM, Peake IR & Goodeve AC (1999) Mutational analysis of the von Willebrand factor gene in 27 families from Turkey with von Willebrand disease. THROMBOSIS AND HAEMOSTASIS, 283-283.
  • Banypersad SM, Makris M, Daly ME, Peake IR & Preston FE (1999) Increased prevalence of compound heterozygosity for the C677T and A1289C dimorphisms in the methylene tetrahydrofolate reductase gene in patients with factor V Leiden and venous thrombosis. THROMBOSIS AND HAEMOSTASIS, 71-71.
  • Allen S, Abuzenadah AM, Blagg J, Hinks J, Nesbitt IM, Daly ME, Goodeve A, Gursel T, Ingerslev J & Peake IR (1999) CYS788ARG and CYS1225GLY mutations in von Willebrand factor result in combined type 1 and type 2N von Willebrand disease. THROMBOSIS AND HAEMOSTASIS, 686-686.
  • Allen S, Abuzenadah AM, Daly ME, Goodeve A, Gursel T, Ingerslev J & Peake IR (1999) Arg273Trp mutation in the von Willebrand factor propeptide results in impaired secretion. THROMBOSIS AND HAEMOSTASIS, 687-687.
  • Frost L, Wilson G, Goodeve A, Peake I & Vora A (1999) Minimal residual disease clearance in standard risk childhood ALL patients treated on UKALL X and XI protocols.. BRITISH JOURNAL OF HAEMATOLOGY, 105, 80-80.
  • Hinks JL, Winship PR, Makris M, Preston FE, Peake IR & Goodeve AC (1999) Rapid detection of factor IX gene mutations using conformation sensitive gel electrophoresis.. BRITISH JOURNAL OF HAEMATOLOGY, 105, 36-36.
  • Williams IJ, Abuzenadah A, Winship PR, Preston FE, Dolan G, Wright J, Peake IR & Goodeve AC (1998) . Thrombosis and Haemostasis, 79(04), 723-726.
  • Daly ME, Makris M, Preston FE, Peake IR & Beauchamp NJ (1998) . Thrombosis and Haemostasis, 79(06), 1086-1091.
  • Ludlam CA, Colvin BT, Hill FGH, Preston FE, Wasseem N, Bagnall R, Peake IR, Berntorp E, Bunschoten EPM, Fijnvandraat K , Kasper CK et al (1998) . Thrombosis and Haemostasis, 79(04), 762-766.
  • Peake I (1998) . Haemophilia, 4(s2), 24-25.
  • Lee CA, Kessler CM, Varon D, Martinowitz U, Heim M & PEAKE IAN (1998) . Haemophilia, 4(4), 346-349.
  • Frost L, Wilson G, Goodeve A, Peake I & Vora A (1998) Influence of post-induction treatment intensity on rates of minimal residual disease clearance in childhood ALL.. BLOOD, 92(10), 394A-394A.
  • Leach M, Makris M, Beauchamp NJ, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ & Preston FE (1998) Diagnosis and thrombotic risk in a cohort with genetically confirmed protein S deficiency.. BLOOD, 92(10), 561A-561A.
  • Gari MA, Goodeve AC, Wilson G, Winship PR, Langabeer S, Linch D, Vandenberghe E, Peake IR & Reilly JT (1998) c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia.. BLOOD, 92(10), 592A-593A.
  • Williams IJ, Peake IR & Goodeve AC (1998) Recombinate PUP mutation study: Examination of the relationship between factor VIII mutations and inhibitor development.. BLOOD, 92(10), 102B-102B.
  • Beauchamp NJ, Pike RN, Daly M, Butler L, Makris M, Dafforn TR, Zhou A, Fitton HL, Preston FE, Peake IR & Carrell RW (1998) . Blood, 92(8), 2696-2706.
  • Beauchamp NJ, Pike RN, Daly M, Butler L, Makris M, Dafforn TR, Zhou A, Fitton HL, Preston FE, Peake IR & Carrell RW (1998) . Blood, 92(8), 2696-2706.
  • Vora A, Frost L, Goodeve A, Wilson G, Ireland RM, Lilleyman J, Eden T, Peake I & Richards S (1998) . Blood, 92(7), 2334-2337.
  • Vora A, Frost L, Goodeve A, Wilson G, Ireland RM, Lilleyman J, Eden T, Peake I & Richards S (1998) . Blood, 92(7), 2334-2337.
  • Tagariello G, Belvini D, Are A, Salviato R, Davoli PG, Goodeve AC, Williams I, Peake IR & Traldi A (1998) Genetic carrier state diagnosis of haemophilia: Experience at the Haemophilia Centre in Castelfranco Veneto. THROMBOSIS RESEARCH, 91(3), S63-S64.
  • Frost L, Richards S, Goodeve A, Wilson G, Lilleyman J, Eden T, Peake I & Vora A (1998) Late relapsing childhood acute lymphoblastic leukaemia.. BRITISH JOURNAL OF HAEMATOLOGY, 101, 31-31.
  • Gari MA, Goodeve AC, Wilson G, Winship PR, Vandenberghe E, Peake IR & Reily JT (1998) c-kit mutational analysis in acute and chronic myeloproliferative disorders.. BRITISH JOURNAL OF HAEMATOLOGY, 101, 28-28.
  • Allen S, Blagg J, Abuzenadah AM, Daly ME, Goodeve A & Peake IR (1998) Pro2063Ser mutation in von Willebrand factor results in impaired intracellular transport and secretion.. BRITISH JOURNAL OF HAEMATOLOGY, 101, 67-67.
  • Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR & Miller GJ (1997) . Thrombosis and Haemostasis, 78(06), 1426-1429.
  • Hay CRM, Oilier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FGH, Preston FE & Peake IR (1997) . Thrombosis and Haemostasis, 77(02), 234-237.
  • Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FG, Preston FE & Peake IR (1997) HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.. Thromb Haemost, 77(2), 234-237.
  • Frost L, Goodeve A, Wilson G, Peake I, Barker H & Vora A (1997) . British Journal of Haematology, 98(4), 992-994.
  • Frost L, Richards S, Goodeve A, Wilson G, Lilleyman J, Eden T, Peake I & Vora A (1997) Late relapsing childhood lymphoblastic leukaemia.. BLOOD, 90(10), 2492-2492.
  • Williams IJ, Preston FE, Dolan G, Peake IR & Goodeve AC (1997) . Blood Coagulation & Fibrinolysis, 8(7), 469-469.
  • Steeds R, Osborn SV, Daly ME, Hampton KK, Smillie D, Channer KS & Peake IR (1997) . Clinical Science, 93(s37), 10P-10P.
  • Daly ME, Roberts L, Beauchamp NJ, Makris M, Preston FE & Peake IR (1997) The C677F polymorphism in the methylene tetrahydrofolate reductase gene: Interaction with factor V Leiden in thrombophilia patients. THROMBOSIS AND HAEMOSTASIS, P2154-P2154.
  • Beauchamp NJ, Rimmer J, Cooper PC, Bayliss P, Makris M, Preston FE, Peake IR & Daly ME (1997) Influence of founder effect and mutations causing borderline phenotypes on the prevalence of antithrombin deficiency in thrombophilic patients. THROMBOSIS AND HAEMOSTASIS, P1764-P1764.
  • Holliday H, Ellis SP, Peake IR & Winship PR (1997) Two novel polymorphisms in the promoter region of the factor IX gene show differential binding of nuclear factors. THROMBOSIS AND HAEMOSTASIS, P1881-P1881.
  • Winship PR, Nichols CE, Scattergood A & Peake IR (1997) Association between Msel RFLP genotype and factor IX level in normal females; evidence for a polymorphic oestrogen response element in the factor IX gene promoter. THROMBOSIS AND HAEMOSTASIS, P1882-P1882.
  • Makris M, Preston FE, Beauchamp NJ, Hampton KK, Daly ME, Cooper P, Bayliss P & Peake IR (1997) Co-inheritance of the 20210A allele of the prothrombin gene increases the thrombotic risk in subjects with familial thrombophilia. THROMBOSIS AND HAEMOSTASIS, SC672-SC672.
  • Cooper PC, Beauchamp NJ, Daly ME, Bayliss P, Peake IR, Makris M & Preston FE (1997) The prothrombin 20210 G->A variant is associated with increased levels of prothrombin and increased incidence of venous thrombosis. THROMBOSIS AND HAEMOSTASIS, O1546-O1546.
  • Wilson G, Frost L, Goodeve A, Vandenberghe E, Peake I & Reilly J (1997) . Blood, 89(8), 3064-3064.
  • Hop C, Guilliatt A, Daly M, Peake I, vanMourik JA & Pannekoek H (1997) Von Willebrand factor and the Weibel-Palade body. THROMBOSIS AND HAEMOSTASIS, OC691-OC691.
  • Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE & Peake IR (1996) . Thrombosis and Haemostasis, 75(06), 959-964.
  • Nesbitt IM, Goodeve AC, Preston FE & Peake IR (1996) . Thrombosis and Haemostasis, 76(05), 820-821.
  • Hay CRM, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC & Peake IR (1996) HLA class II profile: A determinant of factor VIII inhibitor development in severe haemophilia A.. BLOOD, 88(10), 1306-1306.
  • Daly ME, Guilliatt AM, Blagg JL & Peake IR (1996) The expression of von Willebrand factor (VWF) in endothelial cell lines ECV304 and EAhy926 following transfection with wild type (WT) and/or mutant VWF expression plasmids.. BLOOD, 88(10), 2951-2951.
  • Beauchamp NJ, Daly ME, Cooper PC, Noble J, Bayliss P, Makris M, Preston FE & Peake IR (1996) . Blood Coagulation & Fibrinolysis, 7(7), 734-734.
  • Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE & Peake IR (1996) . Blood, 88(5), 1700-1707.
  • Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE & Peake IR (1996) . Blood, 88(5), 1700-1707.
  • Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE & Peake IR (1996) The molecular basis of protein S deficiency in four unrelated kindred.. BRITISH JOURNAL OF HAEMATOLOGY, 93, 17-17.
  • L'toole O, Raj H, Peake I, Morice AH & Channer KS (1996) . Clinical Science, 90(s34), 22P-22P.
  • Naylor JA, Nicholson P, Goodeve A, Hassock S, Peake I & Giannelli F (1996) . BLOOD, 87(8), 3255-3261.
  • Goodeve AC, Tagariello G, Chuansumrit A, Preston FE & Peake IR (1996) . Blood Coagulation & Fibrinolysis, 7(7), 672-677.
  • Peake I (1995) . Thrombosis and Haemostasis, 74(01), 040-044.
  • Peake I (1995) Molecular genetics and counselling in haemophilia.. Thromb Haemost, 74(1), 40-44.
  • Wood N, Standen GR, Murray EW, Lillicrap D, Holmberg L, Peake IR & Bidwell J (1995) . British Journal of Haematology, 89(1), 152-156.
  • Pérez‐Casal M, Daly M, Peake I & Batlle J (1995) . American Journal of Hematology, 48(2), 140-140.
  • VARADI K, MORITZ B, LANG H, BAUER K, PRESTON E, PEAKE I, RIVARD GE, KEIL B & SCHWARZ HP (1995) . British Journal of Haematology, 90(4), 884-891.
  • PEAKE IAN, SELIGSOHN URI, GITEL S, KITCHEN S & ZIVELIN A (1995) . Haemophilia, 1(3), 159-164.
  • PEAKE IAN (1995) . Haemophilia, 1(S1), 40-43.
  • Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE & Peake IR (1995) Identification of two protein S gene mutations in two kindred with deficiency of protein S and APC resistance. BLOOD, 86(10), 1426-1426.
  • Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, Ketterling RP, Kazazian HHJ, Negrier C & Vinciguerra C (1995) . Blood, 86(6), 2206-2212.
  • Guilliatt AM, Blagg JL, Daly ME & Peake IR (1995) . Blood Coagulation & Fibrinolysis, 6(6), 591-591.
  • HALL AJ, PEAKE IR & WINSHIP PR (1995) IDENTIFICATION OF MULTIPLE ELEMENTS REGULATING TRANSCRIPTION OF THE PROTEIN-S GENE. THROMBOSIS AND HAEMOSTASIS, 73(6), 1257-1257.
  • NESBITT IM, GUILLIATT AM, GOODEVE AC, PRESTON FE & PEAKE IR (1995) PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF TYPE-2N VON-WILLEBRAND DISEASE. THROMBOSIS AND HAEMOSTASIS, 73(6), 1169-1169.
  • SPRAY JRK, NICHOLS C, PEAKE IR & WINSHIP PR (1995) STEROID-HORMONE RESPONSIVE AND LIVER-SPECIFIC ELEMENTS REGULATE TRANSCRIPTION OF THE HUMAN PROTEIN-C GENE. THROMBOSIS AND HAEMOSTASIS, 73(6), 1255-1255.
  • BEAUCHAMP N, PRESTON FE, DALY M, MAKRIS M & PEAKE IR (1995) COMPARISON OF THE THROMBOTIC RISK IN GROUPS HETEROZYGOUS AND HOMOZYGOUS FOR THE FACTOR-V-G1691A MUTATION CONFERRING APC RESISTANCE. THROMBOSIS AND HAEMOSTASIS, 73(6), 1367-1367.
  • Naylor JA, Goodeve AC, Nicholson P, Hassock S, Peake IR & Giannelli F (1995) . Blood Coagulation & Fibrinolysis, 6(2), 155-155.
  • Nesbitt IM, Guilliatt AM, Goodeve AC, Preston FE & Peake IR (1995) . Blood Coagulation & Fibrinolysis, 6(2), 178-178.
  • Chuansumrit A, Goodeve A, Sasanakul W, Peake IR, Pintadit P, Hathirat P, Preston FE & Isarangkul P (1995) DNA polymorphisms for carrier detection of hemophilia in Thailand.. Southeast Asian J Trop Med Public Health, 26 Suppl 1, 201-206.
  • Peake I & Tuddenham E (1994) . Thrombosis and Haemostasis, 72(03), 475-476.
  • Hall AJ, Chuansumrit A, Peake IR & Winship PR (1994) . Thrombosis and Haemostasis, 72(06), 799-803.
  • Henin C, Makris M, Brown J, Peake IR & Preston EF (1994) . British Journal of Haematology, 87(1), 215-217.
  • Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE & Peake IR (1994) . British Journal of Haematology, 88(1), 219-222.
  • TUDDENHAM EGD, SCHWAAB R, SEEHAFER J, MILLAR DS, GITSCHIER J, HIGUCHI M, BIDICHANDANI S, CONNOR JM, HOYER LW, YOSHIOKA A , PEAKE IR et al (1994) HEMOPHILIA-A - DATABASE OF NUCLEOTIDE SUBSTITUTIONS, DELETIONS, INSERTIONS AND REARRANGEMENTS OF THE FACTOR-VIII GENE, 2ND EDITION (VOL 22, PG 3511, 1994). NUCLEIC ACIDS RESEARCH, 22(22), 4850-4868.
  • Tuddenham EGD, Schwaab R, Seehafer J, Millar DS, Gitschier J, Higuchi M, Bidichandani S, Connor JM, Hoyer LW, Yoshioka A , Peake IR et al (1994) . Nucleic Acids Research, 22(22), 4851-4868.
  • Beauchamp N, Daly M, Cooper P, Preston FE & Peake I (1994) . The Lancet, 344(8923), 694-695.
  • Tuddenham EGD, Schwaab R, Seehafer J, Millar DS, Gitschier J, Higuchi M, Bidichandani S, Connor JM, Hoyer LW, Yoshioka A , Peake IR et al (1994) . Nucleic Acids Research, 22(17), 3511-3533.
  • Goodeve AC, Preston FE & Peake IR (1994) . The Lancet, 343(8893), 329-330.
  • SCHWARZ HP, VARADI K, MORITZ B, LANG H, BAUER K, PRESTON E, PEAKE I & RIVARD GE (1994) A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANCE. BLOOD, 84(10), A84-A84.
  • PEAKE I & TUDDENHAM E (1994) A STANDARD NOMENCLATURE FOR FACTOR-VIII AND FACTOR-IX GENE-MUTATIONS AND ASSOCIATED AMINO-ACID ALTERATIONS. THROMBOSIS AND HAEMOSTASIS, 72(3), 475-476.
  • Goodeve AC, Chuansumrit A, Sasanakul W, Isarangkura P, Preston FE & Peake IR (1994) . Blood Coagulation & Fibrinolysis, 5(1), 29-36.
  • Peake I (1993) . Thrombosis and Haemostasis, 69(03), 216-216.
  • Winship PR, Nichols CE, Chuansumrit A & Peake IR (1993) . British Journal of Haematology, 84(1), 101-105.
  • Pérez-Casal M, Daly M & Peake A (1993) . Human Molecular Genetics, 2(12), 2159-2161.
  • Peake I (1993) Detection of carriers and prenatal diagnosis of bleeding disorders.. Southeast Asian Journal of Tropical Medicine and Public Health, 24 Suppl 1, 37-40.
  • Peake IR, Lillicrap DP, Boulyjenkov V, Bri??t E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K & Tuddenham EGD (1993) . Blood Coagulation & Fibrinolysis, 4(2), 313-344.
  • PEREZCASAL M, DALY M & PEAKE I (1993) MBO-I POLYMORPHISM IN THE VON-WILLEBRAND-FACTOR PSEUDOGENE. THROMBOSIS AND HAEMOSTASIS, 69(6), 1178-1178.
  • PEAKE I (1993) BLOOM,ARTHUR,LESLIE - OBITUARY. THROMBOSIS AND HAEMOSTASIS, 69(3), 216-216.
  • HALL A, PEAKE I & WINSHIP PR (1993) SINGLE-BASE CHANGES IN C/EBP BINDING-SITE WITHIN THE FACTOR-IX PROMOTER AND THEIR RELATIVE EFFECTS ON TRANSCRIPTION LEVELS. THROMBOSIS AND HAEMOSTASIS, 69(6), 767-767.
  • WINSHIP PR & PEAKE I (1993) TESTOSTERONE-INDUCED RECOVERY OF FACTOR-IX TRANSCRIPTION IN PATIENTS WITH THE HEMOPHILIA-B LEYDEN PHENOTYPE. THROMBOSIS AND HAEMOSTASIS, 69(6), 847-847.
  • PEAKE I, THOMSON J, POLLER L, CROWE W & GOODEVE A (1993) THE FACTOR-VII ARG-353 GLN POLYMORPHISM AS A PREDICTOR OF HIGH PLASMA FACTOR-VII LEVELS IN A NORMAL POPULATION. THROMBOSIS AND HAEMOSTASIS, 69(6), 624-624.
  • Peake IR, Lillicrap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM & Nicolaides K (1993) Haemophilia: strategies for carrier detection and prenatal diagnosis.. Bulletin of the World Health Organization, 71(3-4), 429-458.
  • Peake I (1992) . Thrombosis and Haemostasis, 67(02), 277-280.
  • Dannatt AH, Goodwin SJ, Dasani H, Bowen DJ, Peake IR & Bloom AL (1992) The relationship of HIV-1 viral sequences detected by the polymerase chain reaction in haemophilic patients to clinical and other markers of infection.. Clin Lab Haematol, 14(1), 1-7.
  • Kasper C, Mannucci P, Bulyzhenkov V, Brettler D, Chuansumrit A, Heijnen L, Isarankura P, Kernoff P, Peake I, Rickard K , Schulman S et al (1992) . Seminars in Thrombosis and Hemostasis, 18(01), 1-10.
  • Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kernoff PBA, Peake I, Rickard KA , Schulman S et al (1991) . Vox Sanguinis, 61(3), 221-224.
  • Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kemoff PBA, Peake I, Rickard KA , Schulman S et al (1991) . Vox Sanguinis, 61(3), 221-224.
  • Tuddenham EGD, Cooper DN, Gitschier J, Higuchi M, Hoyer LW, Yoshioka A, Peake IR, Schwaab R, Olek K, Kazazian HH , Lavergne JM et al (1991) . Nucleic Acids Research, 19(18), 4821-4833.
  • Peake I & Winship P (1991) . Blood, 78(1), 250-250.
  • Peake I & Winship P (1991) . Blood, 78(1), 250-250.
  • Bowen DJ, Webb CE, Peake IR & Bloom AL (1991) . Nucleic Acids Research, 19(11), 3159-3159.
  • Standen GR & Peake IR (1991) The molecular biology of von Willebrand's disease.. Q J Med, 79(289), 381-389.
  • Murray EW, Giles AR, Bridge PJ, Peake IR & Lillicrap DP (1991) . Blood, 77(7), 1476-1483.
  • RICKLES F, HOYER L, JOIST H, PEAKE I, ALEDORT L, KASPER C, LUSHER J, THOMPSON A, KIM H & BRIET E (1991) INHIBITOR DETECTION - ASSAYS, THEIR VARIATION, SIGNIFICANCE AND INTERPRETATION - IMMUNOCHEMISTRY OF FACTOR-VIII-C AND FACTOR-IX-C INHIBITORS - EPITOPES AND MECHANISM OF ACTION - DISCUSSION. BLOOD COAGULATION & FIBRINOLYSIS, 2, 17-20.
  • THOMPSON A, LOZIER J, BRIET E, DIMICHELE D, HOOTS K, KASPER C, LUSHER J, ALEDORT L, PEAKE I, GUERIN V & HOYER L (1991) FACTOR-IX INHIBITORS IN HEMOPHILIA-B PATIENTS, THEIR INCIDENCE AND PROSPECTS FOR DEVELOPMENT WITH HIGH-PURITY FACTOR-IX PRODUCTS - ANAMNESTIC RESPONSE FOLLOWING INFUSION OF PROTHROMBIN COMPLEX CONCENTRATES (PCC) AND ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES (APCC) IN HEMOPHILIA-A PATIENTS WITH INHIBITORS - DISCUSSION. BLOOD COAGULATION & FIBRINOLYSIS, 2, 59-62.
  • ALEDORT L, HOOTS K, ROBERTS H, LUSHER J, HOYER L, GILES A, PENNER J, KISKER T, JOIST H, BLANCHETTE V & PEAKE I (1991) FACTOR-VIII INHIBITORS IN A HEMOPHILIC POPULATION TREATED WITH LOW AND HIGH-PURITY FVIII CONCENTRATES - DISCUSSION. BLOOD COAGULATION & FIBRINOLYSIS, 2, 25-30.
  • Taylor SAM, Liddell MB, Peake IR, Bloom AL & Lillicrap DP (1990) . British Journal of Haematology, 75(2), 217-221.
  • Standen GR, Bignell P, Bowen DJ, Peake IR & Bloom AL (1990) . British Journal of Haematology, 76(2), 242-249.
  • Bignell P, Standen GR, Bowen DJ, Peake IR & Bloom AL (1990) . The Lancet, 336(8715), 638-639.
  • Peake IR, Bowen D, Bignell P, Liddell MB, Sadler JE, Standen G & Bloom AL (1990) . Blood, 76(3), 555-561.
  • Peake IR, Bowen D, Bignell P, Liddell MB, Sadler JE, Standen G & Bloom AL (1990) . Blood, 76(3), 555-561.
  • Peake I (1990) . La Ricerca in Clinica e in Laboratorio, 20(3), 177-185.
  • Peake IR, Liddell MB, Moodie P, Standen G, Mancuso DJ, Tuley EA, Westfield LA, Sorace JM, Sadler JE & Verweij CL (1990) . Blood, 75(3), 654-661.
  • Peake IR, Liddell MB, Moodie P, Standen G, Mancuso DJ, Tuley EA, Westfield LA, Sorace JM, Sadler JE & Verweij CL (1990) . Blood, 75(3), 654-661.
  • Liddell MB, Lillicrap DP, Peake IR & Bloom AL (1989) . British Journal of Haematology, 72(2), 208-215.
  • Moffat EH, Furlong RA, Dannatt AHG, Bloom AL & Peake IR (1989) . British Journal of Haematology, 71(1), 85-90.
  • Liddell MB, Peake IR, Taylor SAM, Lillicrap DP, Giddings JC & Bloom AL (1989) . British Journal of Haematology, 72(4), 556-560.
  • Peake I (1989) . Journal of Clinical Pathology, 42(7), 673-676.
  • FURLONG RA, CHESHAM J & PEAKE IR (1988) . Clinical & Laboratory Haematology, 10(3), 295-306.
  • Moodie P, Liddell MB, Peake IR & Bloom AL (1988) . British Journal of Haematology, 70(1), 77-84.
  • Matthews RJ, Peake IR, Bloom AL & Anson DS (1988) . Journal of Medical Genetics, 25(11), 779-780.
  • Furlong RA, Welch AN & Peake IR (1987) . British Journal of Haematology, 66(3), 341-348.
  • Matthews RJ, Anson DS, Peake IR & Bloom AL (1987) . Journal of Clinical Investigation, 79(3), 746-753.
  • Lillicrap DP, Liddell MB, Matthews RJ, Peake IR & Bloom AL (1986) . British Journal of Haematology, 62(3), 557-565.
  • Peake IR, Bloom AL & Opie L (1986) . The Lancet, 327(8493), 1335-1336.
  • Thomas JE, Peake IR, Giddings JC, Welch AN & Bloom AL (1985) . Thrombosis and Haemostasis, 53(01), 143-147.
  • Peake IR (1985) . BioEssays, 2(3), 110-113.
  • Peake IR, Lillicrap DP, Liddell MB, Matthews RJ & Bloom AL (1985) . The Lancet, 326(8462), 1003-1004.
  • Peake IR (1984) . Clinical Science, 67(6), 561-567.
  • Furlong RA & Peake IR (1984) . Thrombosis Research, 34(5), 379-387.
  • Beaudet A, Peake IR, Furlong BL & Bloom AL (1984) . The Lancet, 323(8387), 1182-1182.
  • Peake IR, Furlong BL & Bloom AL (1984) . The Lancet, 323(8371), 242-243.
  • McCallum CJ, Peake IR, Newcombe RG & Bloom AL (1983) . Thrombosis and Haemostasis, 50(03), 757-757.
  • Chediak J, Peake I & Bloom A (1983) . Thrombosis and Haemostasis, 50(02), 509-512.
  • Furlong RA & Peake IR (1983) . British Journal of Haematology, 53(1), 55-63.
  • Yoshioka A, Peake IR, Furlong BL, Furlong RA, Giddings JC & Bloom AL (1983) . British Journal of Haematology, 55(1), 27-36.
  • Furlong BL & Peake IR (1983) . British Journal of Haematology, 53(4), 641-653.
  • Peake IR, Newcombe RG, Davies BL, Furlong RA, Ludlam CA & Bloom AL (1981) . British Journal of Haematology, 48(4), 651-660.
  • Furlong RA, Peake IR & Bloom AL (1981) . British Journal of Haematology, 48(4), 643-650.
  • Kemball-Cook G, Furlong RA, Peake IR & Barrowcliffe TW (1981) . Thrombosis Research, 23(1-2), 193-196.
  • Davies BL, Furlong RA & Peake IR (1981) . Thrombosis Research, 22(1-2), 87-96.
  • Barrowcliffe TW, Kemball-Cook G, Morris G, Holt JC, Furlong RA & Peake IR (1981) Factor VIII-related activities in therapeutic concentrates.. J Lab Clin Med, 97(3), 429-438.
  • Nilsson IM, Peake IR, Bloom AL, Meyer D, Veltkamp J & Green D (1980) . Thrombosis and Haemostasis, 43(02), 167-168.
  • GIDDINGS JC, PIOVELLA F, RICETTI M, JARVIS A, PEAKE IR & BLOOM AL (1980) . Clinical & Laboratory Haematology, 2(2), 121-128.
  • Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA & Bloom AL (1980) . British Journal of Haematology, 45(3), 499-511.
  • Mibashan RS, Rodeck CH, Furlong RA, Bains L, Peake IR, Thumpston JK, Gorer R & Bloom AL (1980) . The Lancet, 316(8202), 994-997.
  • Shaw E, Giddings JC, Peake IR & Bloom AL (1979) . British Journal of Haematology, 41(4), 585-596.
  • Peake IR, Bloom AL, Giddings JC & Ludlam CA (1979) . British Journal of Haematology, 42(2), 269-281.
  • Rodeck CH, Mibashan RS, Peake IR & Bloom AL (1979) . The Lancet, 314(8143), 637-638.
  • Bloom AL & Peake IR (1979) . Thrombosis Research, 15(3-4), 505-512.
  • Bloom AL, Peake IR, Furlong RA & Davies BL (1979) . Thrombosis Research, 16(5-6), 847-852.
  • PIOVELLA F (1978) . The Lancet, 312(8095), 888-889.
  • Sixma JJ, Over J, Bouma BN, Bloom AL & Peake IR (1978) . Thrombosis Research, 12(5), 929-935.
  • Peake IR & Bloom AL (1978) . The Lancet, 311(8062), 473-475.
  • Shearn SAM, Peake IR, Giddings JC, Humphrys J & Bloom AL (1977) . Thrombosis Research, 11(1), 43-56.
  • Peake IR & Bloom AL (1977) . Thrombosis Research, 10(1), 27-32.
  • Bloom AL, Peake IR, Giddings JC, Shearn SM & Tuddenha EGD (1976) . The Lancet, 307(7949), 46-46.
  • Tuddenham EGD, Shearn SAM, Peake IR, Giddings JC & Bloom AL (1974) . British Journal of Haematology, 26(4), 669-677.
  • Shearn SAM, Giddings JC, Peake IR & Bloom AL (1974) . Thrombosis Research, 5(5), 585-599.
  • Tuddenham EG, Shearn SA, Peake IR, Giddings JC & Bloom AL (1974) Proceedings: Factor-VIII-related antigen in the human foetus and its synthesis in tissue culture.. Br J Haematol, 28(1), 143.
  • PEAKE I (1974) . The Lancet, 304(7874), 222-223.
  • Peake IR, Bloom AL & Giddings JC (1974) . New England Journal of Medicine, 291(3), 113-117.
  • Bloom AL, Peake IR & Giddings JC (1974) . The Lancet, 303(7857), 576-576.
  • Bloom AL, Peake IR & Giddings JC (1973) . Thrombosis Research, 3(4), 389-404.
  • Peake IR, Bloom AL, Shearn SM & Giddings JC (1973) . The Lancet, 302(7830), 674-675.
  • Bloom AL, Giddings JC, Peake IR, Weiss H, Bouma BN, Sixma JJ, Van Mourik JA & Mochtar IA (1973) . The Lancet, 301(7810), 1000-1001.
  • Bloom AL, Giddings JC & Peake IR (1973) . The Lancet, 301(7804), 661-662.
  • PEAKE I & DALY M () . International Journal of Laboratory Hematology, 17(3), 264-266.
  • Peake L () . Arzneimittelforschung, 49(02), 163-165.
  • Bowen DJ, Thomas P, Webb CE, Bignell P, Peake IR & Bloom AL () . British Journal of Haematology, 77(4), 559-560.
  • () . QJM: An International Journal of Medicine.

Book chapters

  • Goodeve AC & Peake IR (2013) (pp. 204-215). Wiley
  • Lillicrap D, Rodeghiero F & Peake I (2011) (pp. 127-136). Wiley
  • Goodeve A & Peake I (2008) (pp. 137-146). Wiley
  • Daly M, Goodeve A, Winship P & Peake I (1998) , Principles of Molecular Medicine (pp. 209-217). Humana Press
  • PEAKE IR & MATTHEWS RJ (1987) , Protides of the Biological Fluids (pp. 33-35). Elsevier

Conference proceedings

  • Baronciani L, Budde U, Stufano F, Peyvandi F, Goodeve A, Schneppenheim R, Badiee Z, Baghaipour MR, Battle J, Berntorp E , Bodo I et al (2019) EVALUATION OF THE VON WILLEBRAND FACTOR (VWF) INHIBITOR IN A LARGE COHORT OF EUROPEAN AND IRANIAN PATIENTS PREVIOUSLY DIAGNOSED WITH TYPE 3 VON WILLEBRAND DISEASE (VWD3) ENROLLED INTO THE 3WINTER-IPS PROJECT. HAEMATOLOGICA, Vol. 104 (pp 24-24)
  • Federici AB, Badiee Z, Baghaipour M-R, Castaman G, Eshghi P, Goudemand J, Hay CRM, Hoorfar H, Karimi M, Keikhaei B , Lassila R et al (2018) . Blood, Vol. 132(Supplement 1) (pp 2464-2464)
  • Tosetto A, Christopherson PA, Eikenboom JCJ, Grabell J, James PD, Montgomery RR, Peake I, Silva M & Investigators ZP (2018) . Blood, Vol. 132(Supplement 1) (pp 1180-1180)
  • Tosetto A, Badiee Z, Baghaipour M-R, Baronciani L, Battle J, Berntorp E, Bodó I, Budde U, Castaman G, Eikenboom JCJ , Eshghi P et al (2018) . Blood, Vol. 132(Supplement 1) (pp 2465-2465)
  • Baronciani L, Peyvandi F, Goodeve A, Schneppenheim R, Badiee Z, Baghaipour M-R, Battle J, Berntorp E, Bodó I, Budde U , Cairo A et al (2018) . Blood, Vol. 132(Supplement 1) (pp 1184-1184)
  • Webster SJ, Cartwright A, Hampshire DJ, Peake IR, Goodeve AC & EU-VWD and ZPMCB-VWD study groups (2015) . Journal of Thrombosis and Haemostasis, Vol. 13(Suppl. 2) (pp 23-23), 20 June 2015 - 25 June 2015.
  • Mufti A, Goodeve A, Peake I, Hampshire D & EU-VWD and ZPMCB-VWD study groups (2015) . Journal of Thrombosis and Haemostasis, Vol. 13(Suppl. 2) (pp 251-251), 20 June 2015 - 25 June 2015.
  • Dsouza MM, Webster SJ, McMaster J, Cartwright A, Budde U, Peake IR, Goodeve AC, Hampshire DJ & EU-VWD and ZPMCB-VWD study groups (2015) . Journal of Thrombosis and Haemostasis, Vol. 13(Suppl. 2) (pp 508-508), 20 June 2015 - 25 June 2015.
  • Cartwright A, Webster SJ, Jacobi PM, Hickson N, Budde U, Peake IR, Goodeve AC, Haberichter SL, Hampshire DJ & EU-VWD and ZPMCB-VWD study groups (2015) . Journal of Thrombosis and Haemostasis, Vol. 13(Suppl. 2) (pp 505-505), 20 June 2015 - 25 June 2015.
  • Webster SJ, Hampshire DJ, Schneppenheim R, Bellissimo D, James P, Theophilus B, Peake IR, Goodeve AC & EU-VWD and ZPMCB-VWD study groups (2015) . Journal of Thrombosis and Haemostasis, Vol. 13(Suppl. 2) (pp 126-126), 20 June 2015 - 25 June 2015.
  • Cartwright A, Christopherson PA, Perry CL, Haberichter SL, Hampshire D, Peake IR, Goodeve A, Montgomery RR, Bellissimo DB & Zimmerman Program Investigators (2014) Characterization and expression of an in-frame exon 33-34 deletion causing type 1 VWD. Blood, Vol. 124
  • Goodeve AC, Hampshire D, Batlle J, Budde U, Castaman G, Eikenboom HCJ, Federici AB, Schneppenheim R & Peake IR (2013) Re-evaluation of sequence variation in type 1 von Willebrand disease in the MCMDM-1VWD cohort. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 11 (pp 413-414)
  • Mufti A, Lillicrap D, Peake IR, Goodeve AC & Hampshire D (2013) Investigation of the effect of CLEC4M on plasma von Willebrand factor level in the general population. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 11 (pp 552-553)
  • Cartwright A, Hampshire DJ, Bloomer L, Al-Buhairan AM, Vijzelaar NCP, Budde U, Eikenboom HCJ, Schneppenheim R, Peake IR & Goodeve AC (2013) Characterisation of large in-frame deletions contributing to type 1 VWD pathogenesis in the MCMDM-1VWD study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 11 (pp 117-118)
  • Alyami NH, Hampshire D, Goudemand J, Castaman G, Federici AB, Cartwright A, Peake IR & Goodeve AC (2013) Previously missed mutations in the MCMDM-1VWD type 1 von Willebrand disease study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 11 (pp 415-415)
  • Hampshire DJ, Abuzenadah AM, Al-Shammari NS, Eckert M, Coyle RE, Al-Buhairan AM, Messenger SL, Gursel T, Ingerslev J, Peake IR & Goodeve AC (2011) Characterisation of von Willebrand disease mutational spectrum in a Turkish patient cohort. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9 (pp 914-914)
  • Alyami NH, Hampshire DJ, Goudemand J, Castaman G, Federici AB, Peake IR & Goodeve AC (2011) Missing mutation in type 1 von Willebrand disease in the MCMDM-1 VWD study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9 (pp 914-914)
  • Hampshire DJ, Cartwright A, Bloomer LD, Al-Buhairan AM, Vijzelaar RNCP, Habart D, Hill FGH, Rodeghiero F, Budde U, Eikenboom JCJ , Peake IR et al (2011) Copy number variation is a significant contributor to type 1 VWD pathogenesis in the EU MCMDM-1VWD cohort. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9 (pp 55-56)
  • Hampshire DJ, Bloomer LD, Al-Buhairan AM, Coyle RE, Vijzelaar RNCP, Lillicrap D, James PD, Eikenboom JCJ, Schneppenheim R, Rodeghiero F , Montgomery RR et al (2010) Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease.. BLOOD, Vol. 116(21) (pp 913-913)
  • Hickson N, Hampshire DJ, Winship PR, James PD, Peake IR & Goodeve AC (2009) FUT3 gene determining Lewis blood group antigen expression influences VWF:Ag levels in plasma. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 1147-1147)
  • Hickson N, Hampshire DJ, Winship PR, James PD, Peake IR & Goodeve AC (2009) Associations between the von willebrand factor gene (VWF) variant C.2771G > A (P.R924Q), von willebrand factor antigen (VWF:Ag) and FVIII activity (FVIII:C) levels and its role as a risk factor for type 1 von willebrand disease (VWD). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 11-11)
  • Burghel GJ, Eikenboom JCJ, Schneppenheim R, Budde U, Peake IR, Goodeve AC & Hampshire DJ (2009) Identification of three additional mutations in patients enrolled in the european study, molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 192-192)
  • Daly ME, Dawood BB, Lester WA, Federici AB, Artoni A, Peake IR, Mumford AD, Watson SP & Mundell SJ (2009) Identification of two novel P2Y12 ADP receptor gene defects in patients with type 1 von Willebrand disease. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 158-158)
  • Hampshire DJ, Winship PR, Lillicrap D, Peake IR & Goodeve AC (2009) Use of in silico and in vitro analysis to identify VWF 5¢ regulatory elements. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 7 (pp 255-256)
  • Hampshire DJ, James PD, Lillicrap D, Peake IR & Goodeve AC (2007) . Journal of Thrombosis and Haemostasis, Vol. 5
  • Flood VH, Kautza BC, Miller CA, Branchford BR, Gill JC, Haberichter SL, Morateck PA, Christopherson PA, Perry CL, Friedman KD , Bellissimo DB et al (2007) . Blood, Vol. 110(11) (pp 714-714)
  • Chuansumrit A, Sasanakul W, Williams I, Goodeve A, Kadegasem P & Peake I (2004) . Blood, Vol. 104(11) (pp 4020-4020)
  • Lester WA, Bowen DJ, Cumming A, Collins PW, Watson P, Keeney S, Enayat MS, Keeling D, Pasi KJ, Bolton-Maggs P , Liesner R et al (2003) Variable phenotypic penetrance of von Willebrand factor gene Y1584C heterozygosity in type 1 von Willebrand disease families and its association with enhanced in vitro susceptibility to ADAMTS 13 mediated proteolysis.. BLOOD, Vol. 102(11) (pp 311A-311A)
  • Eikenboom JCJ, van Marion V, Putter H, Garcia EBG, Peake I, Goodeve A, Rodeghiero F, Castaman G, Federici AB, Batlle J , Meyer D et al (2003) Analysis of cosegregation of type 1 Von Willebrands disease phenotype and von Willebrand factor gene haplotypes in the European Multicenter MCMDM-1VWD study.. BLOOD, Vol. 102(11) (pp 90A-90A)
  • Goodeve A, Walker M, Peake I, Rodeghiero F, Castaman G, Federici A, Batlle J, Meyer D, Eikenboom J, Schneppenheim R , Ingerslev J et al (2003) Contribution of ABO blood group to type 1 von Willebrand disease in patients entered in the multicentre MCMDM-1VWD study.. BLOOD, Vol. 102(11) (pp 91A-91A)
  • Hashemi MB, Inbal A, Peake IR, Mikris M, Hampton E & Goodeve AC (2002) Mutational analysis in five families with type 1 von Willebrand disease. BLOOD, Vol. 100(11) (pp 69B-69B)
  • Care RS, Goodeve AC, Abu-Duhier FM, Geertsma-Kleinekoort W, Valk PJM, Lowenberg B, Wilson GA, Gari MA, Peake IR & Reilly JT (2002) Incidence and prognosis of c-kit and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.. BLOOD, Vol. 100(11) (pp 746A-746A)
  • Sadler JE, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A & Mannucci PM (2000) . Thrombosis and Haemostasis, Vol. 84(08) (pp 160-174)
  • Hop C, Guilliatt A, Daly M, de Leeuw HP, Brinkman H-JM, Peake IR, van Mourik JA & Pannekoek H (2000) . Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 20(7) (pp 1763-1768)
  • Frost L, Wilson G, Goodeve A, Gerrard M, Snowden J, Peake I & Vora A (1999) Relapsing precursor B-ALL presenting as CD-10 positive isolated extramedullary lymphoma.. BLOOD, Vol. 94(10) (pp 219B-219B)
  • Coughlan TC, Goodeve AC, Hampton KK, Makris M & Peake IR (1998) Null alleles are not a common cause of type 1 vonWillebrand's disease. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 102(1) (pp 15-15)
  • Nesbitt IM, Goodeve AC, Hampton KK, Preston FE & Peake IR (1998) Two unrelated families with different type 2N VWD mutations share a common splice site mutation.. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 101 (pp 87-87)
  • Abuzenadah AM, Goodeve AC, Gürsel T, Daly ME, Ingerslev J & Peake IR (1998) Mutations in the pro-peptide of VWF causing type 1 and type 3 VWD.. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 101 (pp 67-67)
  • Williams IJ, Peake IR & Goodeve AC (1998) Recombinate PUP mutation study: Relationship between factor VIII mutation and inhibitor development. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 101 (pp 84-84)
  • Abuzenadah AM, Goodeve AC, Ingerslev J, Gursel T & Peake IR (1997) Mutations within the vWF gene resulting in type 1 and type 3 vWD in consanguineous families. THROMBOSIS AND HAEMOSTASIS (pp P2667-P2667)
  • Ollier W, Hay CRM, Pepper L, Cumming A, Keeney S, Goodeve AC, Preston FE, Colvin BT, Hill FGH & Peake IR (1997) HLA class II profile: A determinant of inhibitor development in severe haemophilia A. THROMBOSIS AND HAEMOSTASIS (pp P2657-P2657)
  • Nesbitt IM, Goodeve AC, Daly ME, Hampton KK, Makris M, Preston FE & Peake IR (1997) Mutation at Arg611 in the von Willebrand factor gene results in unclassifiable type 2 von Willebrand disease. THROMBOSIS AND HAEMOSTASIS (pp P2665-P2665)
  • Naylor JA, Nicholson P, Goodeve A, Hassock S, Peake I & Giannelli F (1996) . Blood, Vol. 87(8) (pp 3255-3261)
  • GOODEVE AC, PRESTON FE & PEAKE IR (1995) A RAPID AND COST-EFFECTIVE METHOD FOR ANALYSIS OF DINUCLEOTIDE REPEAT POLYMORPHISMS IN THE FACTOR-VIII GENE. THROMBOSIS AND HAEMOSTASIS, Vol. 73(6) (pp 1221-1221)
  • Peake IR (1995) The molecular biology of haemophilia. HEREDITARY DISEASES AND BLOOD TRANSFUSION, Vol. 30 (pp 3-9)
  • Higins KS, Goodeve AC, Yeo WW, Morice AH & Peake IR (1992) Improved detection of the insertion/deletion polymorphism of the ACE gene and relationship to serum ACE activity in a normotensive U.K. population. British Journal of Clinical Pharmacology, Vol. 34(2) (pp 151)
  • Liddell MB, Anson DS, Lillicrap DP & Peake IR (1987) . Thrombosis and Haemostasis, 6 July 1987 - 10 July 1987.
  • Standen G, Moodie P, Pannekoek H, Verweij CL & Peake IR (1987) . Thrombosis and Haemostasis, 6 July 1987 - 10 July 1987.
  • Matthews RJ, Peake IR & Bloom AL (1987) . Thrombosis and Haemostasis, 6 July 1987 - 10 July 1987.
  • Moodie P, Peake IR, Liddell MB & Bloom AL (1987) . Thrombosis and Haemostasis, 6 July 1987 - 10 July 1987.
  • Matthews RJ, Anson DS, Peake IR & Bloom AL (1987) . Thrombosis and Haemostasis, 6 July 1987 - 10 July 1987.
  • Thomas JE, Furlong RA, Giddings JC, Peake IR & Bloom AL (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Mibashan RS, Peake IR, Newcombe RG, Thumpston JK, Gorer RK, Furlong RA & Rodeck CH (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Peake IR, Newcombe RG, Davies BL, Furlong RA, Ludlam CA & Bloom AL (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Bloom AL, Davies BL, Furlong RA, Giddings JC & Peake IR (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Davies BL, Furlong RA & Peake IR (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Furlong RA, Peake IR & Bloom AL (1981) . Thrombosis and Haemostasis, 13 July 1981 - 17 July 1981.
  • Mibashan RS, Rodeck CH, Thumpston JK, Peake IR & Bloom AL (1979) . Thrombosis and Haemostasis, 15 July 1979 - 20 July 1979.
  • Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA & Bloom AL (1979) . Thrombosis and Haemostasis, 15 July 1979 - 20 July 1979.
  • Barrowcliffe TW, Kemball-Cook G, Morris G, Holt JC & Peake IR (1979) . Thrombosis and Haemostasis, 15 July 1979 - 20 July 1979.
  • Peake IR, Bloom AL & Shearn SAM (1977) . Thrombosis and Haemostasis, 27 June 1977 - 1 July 1977.

Posters

  • Federici AB, Peyvandi F, Budde U, Castaman G, Eikenboom J, Eshghi P, Goodeve A, Goodemand J, Hoorfar H, Karimi M , Peake IR et al (2015) New insights into type 3 von Willebrand disease: the type 3 von Willebrand disease international registries and inhibitor prospective study (3WINTERS-IPS) project update.
Teaching interests

I teach at the postgraduate level.

Professional activities and memberships

I was a partner of the Health and Care Professions Council (HCPC) as a Clinical Scientist, I was also Registration Assessor for HCPC and for the Association of Clinical Scientists.

I am a past President of the International Society on Thrombosis and Haemostasis (ISTH Congress Birmingham 2003) and Chair of the ISTH Council (2006-2008). I am a past Council member of the British Society for Haemostasis and Thrombosis and the European Association for Haemophilia and Allied Disorders. I was also a member of the Education Committee of the European Haematology Association until 2012.